Episode 27 – Using Artificial Intelligence to speed Alzheimer’s studies Saving Minds
-
- Gezondheid en fitness
This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.
This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.
24 min.